| Breakdown | Jan 2026 | Jan 2024 | Jan 2023 | Jan 2022 | Jan 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 617.27M | 729.81M | 720.50M | 470.06M | 323.67M |
| Gross Profit | 87.43M | 123.74M | 146.73M | 74.40M | 49.35M |
| EBITDA | 75.11M | 104.12M | 73.39M | -41.61M | 34.14M |
| Net Income | -30.24M | 39.47M | 1.62M | -69.22M | -4.94M |
Balance Sheet | |||||
| Total Assets | 521.24M | 604.96M | 594.43M | 444.76M | 321.65M |
| Cash, Cash Equivalents and Short-Term Investments | 88.35M | 89.43M | 47.32M | 58.22M | 26.83M |
| Total Debt | 138.25M | 150.96M | 63.02M | 55.46M | 55.58M |
| Total Liabilities | 389.34M | 423.77M | 480.03M | 383.30M | 204.77M |
| Stockholders Equity | 131.90M | 181.67M | 113.95M | 59.83M | 116.96M |
Cash Flow | |||||
| Free Cash Flow | 44.77M | 67.18M | 66.25M | 72.60M | 60.35M |
| Operating Cash Flow | 46.52M | 69.38M | 73.22M | 78.40M | 64.46M |
| Investing Cash Flow | -6.62M | -12.89M | -67.58M | -32.23M | -27.82M |
| Financing Cash Flow | -44.68M | -71.76M | -19.39M | -14.79M | -38.24M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
77 Outperform | £232.23M | 10.47 | 6.46% | 3.68% | 2.11% | 818.58% | |
63 Neutral | £266.20M | -13.78 | -4.92% | 6.33% | -11.01% | 92.56% | |
62 Neutral | £81.90M | 4.75 | 6.44% | 4.25% | -0.49% | -9.92% | |
60 Neutral | $48.67B | 4.58 | -11.27% | 4.14% | 2.83% | -41.78% | |
58 Neutral | £284.40M | -11.70 | -20.40% | 4.98% | -15.42% | -176.11% | |
55 Neutral | £169.08M | -7.44 | -6.04% | 1.09% | -12.14% | -117.78% | |
49 Neutral | £2.83B | -3.51 | -7.54% | 9.68% | -8.08% | -139.61% |